Trial ID: | L0501 |
Source ID: | TCTR20180425001
|
Associated Drug: |
Atorvastatin
|
Title: |
Evaluation of the benefit of supplementation with alpha-tocopherol and ascorbic acid to non-alcoholic fatty liver disease????????s statin therapy in men - Randomized Controlled Trial.
|
Acronym: |
--
|
Status: |
Not Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Non-alcoholic fatty liver disease (NAFLD)
|
Interventions: |
20 mg atorvastatin daily,20 mg atorvastatin daily + 400 IU of vitamin E and 1000 mg of vitamin C daily,Healthy controls.;Active Comparator Drug,Experimental Drug,No Intervention No treatment;Atorvastatin,Atorvastatin+vitC+vit E,Control
|
Outcome Measures: |
Normalization of the activity of antioxidant enzymes At the end of the intervention Enzyme activityNormalization of the serum lipid profile At the end of the intervention Concentration in serum,Normalization of the aminotransferase levels At the end of the intervention Activity in serum,Normalization of CRP levels At the end of the intervention Concentration in serum
|
Sponsor/Collaborators: |
Ss. Cyril and Methodius University in Skopje
|
Gender: |
Male
|
Age: |
35 Years60 Years
|
Phases: |
Not applicable
|
Enrollment: |
--
|
Study Type: |
Interventional
|
Study Designs: |
Randomized
|
Start Date: |
25/04/2018
|
Completion Date: |
31/12/2017
|
Results First Posted: |
--
|
Last Update Posted: |
7 February 2022
|
Locations: |
Republic of Macedonia
|
URL: |
www.thaiclinicaltrials.org/show/TCTR20180425001
|